
Safety Lancet Capiject® 1.5 mm Blade Retractable Push Button Activation Finger, 200/BX
2023-05-28
Safety Lancet Capiject® 1.5 mm Blade Retractable Push Button Activation Finger, 200/BX
2023-05-28
Hover
Safety Lancet Capiject® 1.5 mm Blade Retractable Push Button Activation Finger, 200/BX
$47.43 Original price was: $47.43.$45.06Current price is: $45.06.
Non-stock item, approximate delivery is 2-4 weeks
- Ready to use right out of the box
- Convenient activation for precise and consistent results
- Quick identification of the right product
- Automatic blade or needle retraction styles – the sharp edge is enclosed before and after use
| Manufacturer name | Terumo Medical |
|---|---|
| Model number | 200102 |
| Upc | 894743001253 |
| Quantity | 200/BX |
| Color | Green |
| Brand | Capiject® |
| Usage | Disposable |
| Activation method | Push Button Activation |
| Sterility | Sterile |
| Depth settings | 1.5 mm Depth |
| Incision type | Blade |
| Safety feature | Retractable |
| Target area | Finger |
Related products
-
Safety Lancet Unistik 2 28 Gauge Retractable Push Button Activation Finger, 200/BX
Single-use mechanism to avoid needlestick injuries and prevent cross-infection, and a side firing action to provide extra comfort for both patient and professional
$45.32Original price was: $45.32.$43.05Current price is: $43.05. -
Lancet for Lancing Device Accu-Chek® Preloaded Safety Drum Preloaded Safety Drum Multiple Sites, 102/BX
The lancing device Kit with 102 Accu-Chek® FastClix lancets, primes and releases in a single action A pre-loaded drum hygienically stores up to six lancets (fresh […]
$24.84Original price was: $24.84.$23.60Current price is: $23.60. -
Safety Lancet Unistik 3 21 Gauge Retractable Push Button Activation Finger, 100/BX
Side firing action to provide extra comfort for both patient and professionalUnique comfort zone technology that allows ultimate control and comfort when lancing Comfort zone technology […]
$26.60Original price was: $26.60.$25.27Current price is: $25.27.




Reviews
There are no reviews yet.